OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout
Ali Mirzaesmaeili, Safoura Zangiabadi, Jonathan Raspanti, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 5, pp. 531-535
Open Access | Times Cited: 9
Ali Mirzaesmaeili, Safoura Zangiabadi, Jonathan Raspanti, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 5, pp. 531-535
Open Access | Times Cited: 9
Showing 9 citing articles:
Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis
Yitian Tang, Fatemah Aleithan, Sahib Singh Madahar, et al.
Journal of Autoimmunity (2025) Vol. 152, pp. 103377-103377
Open Access
Yitian Tang, Fatemah Aleithan, Sahib Singh Madahar, et al.
Journal of Autoimmunity (2025) Vol. 152, pp. 103377-103377
Open Access
Nod-like receptors in inflammatory arthritis
Sahib Singh Madahar, A Rodan Gideon, Ali A. Abdul‐Sater
Biomedical Journal (2023) Vol. 47, Iss. 1, pp. 100655-100655
Open Access | Times Cited: 9
Sahib Singh Madahar, A Rodan Gideon, Ali A. Abdul‐Sater
Biomedical Journal (2023) Vol. 47, Iss. 1, pp. 100655-100655
Open Access | Times Cited: 9
TRAF1 Deficiency in Macrophages Drives Exacerbated Joint Inflammation in Rheumatoid Arthritis
Ali Mirzaesmaeili, Ali A. Abdul‐Sater
Biomolecules (2024) Vol. 14, Iss. 7, pp. 864-864
Open Access | Times Cited: 3
Ali Mirzaesmaeili, Ali A. Abdul‐Sater
Biomolecules (2024) Vol. 14, Iss. 7, pp. 864-864
Open Access | Times Cited: 3
Pipeline Therapies for Gout
Kevin Yip, Genna Braverman, Linda Yue, et al.
Current Rheumatology Reports (2023) Vol. 26, Iss. 3, pp. 69-80
Closed Access | Times Cited: 6
Kevin Yip, Genna Braverman, Linda Yue, et al.
Current Rheumatology Reports (2023) Vol. 26, Iss. 3, pp. 69-80
Closed Access | Times Cited: 6
Gout Basic Research: 2023 in Review
Maria Muntiu, Leo A. B. Joosten, Tania O. Crişan
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 3, pp. 220-235
Open Access | Times Cited: 1
Maria Muntiu, Leo A. B. Joosten, Tania O. Crişan
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 3, pp. 220-235
Open Access | Times Cited: 1
New drug targets for the treatment of gout arthritis: what’s new?
Tiago H. Zaninelli, Geovana Martelossi-Cebinelli, Telma Saraiva‐Santos, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 8, pp. 679-703
Closed Access | Times Cited: 4
Tiago H. Zaninelli, Geovana Martelossi-Cebinelli, Telma Saraiva‐Santos, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 8, pp. 679-703
Closed Access | Times Cited: 4
TRAF1 Deficiency in Macrophages Drives Exacerbated Joint Inflammation in Rheumatoid Arthritis
Ali Mirzaesmaeili, Ali A. Abdul‐Sater
(2024)
Open Access | Times Cited: 1
Ali Mirzaesmaeili, Ali A. Abdul‐Sater
(2024)
Open Access | Times Cited: 1
Therapeutic drugs of gout: The progress in target selection
Pei Lin, Zhendong Chen, Jun Lin
International Journal of Rheumatic Diseases (2023) Vol. 27, Iss. 1
Open Access
Pei Lin, Zhendong Chen, Jun Lin
International Journal of Rheumatic Diseases (2023) Vol. 27, Iss. 1
Open Access
